gender affirming pharmacotherapies Flashcards
what are the most commonly used puberty blockers
gonadotropin-releasing hormone (GnRH) agonists
what do gonadotropin-releasing hormone agonists do
inhibit release of sex hormones e.g. testosterone and oestrogen
prevent actions of luteinizing hormone (LH) and
follicle stimulating hormone (FSH)
where is gonadotropin-releasing hormone (GnRH) produced
cells in hypothalamus
gonadotropin-releasing hormone (GnRH) is a decapeptide. what is this
ten amino acids in size
when gonadotropin-releasing hormone (GnRH) is produced, where does it go
released into small blood vessels, carried to pituitary gland
how do gonadotropin-releasing hormone (GnRH) change throughout childhood
low in childhood
inc as puberty begins
what occurs when gonadotropin-releasing hormone (GnRH) reaches the pituitary gland
gonadotropin-releasing hormone (GnRH) activates its receptor, gonadotropin-releasing hormone receptor (GnRHR)
what is the gonadotropin-releasing hormone (GnRH) receptor called
gonadotropin-releasing hormone receptor (GnRHR)
what is the gonadotropin-releasing hormone receptor (GnRHR)
seven transmembrane GPCR
what does gonadotropin-releasing hormone receptor (GnRHR) activation lead to
release of:
luteinizing hormone (LH)
follicle stimulating hormone (FSH)
what function does luteinizing hormone (LH) and follicle stimulating hormone (FSH) have in males
signal for testes to produce testosterone and produce sperm
what does testosterone stimulate
secondary sex characteristics e.g. penis, scrotum, facial hair growth
what function does luteinizing hormone (LH) and follicle stimulating hormone (FSH) have in females
signal ovaries to produce oestrogen hormones e.g. oestradiol and regulate menstrual cycle
stimulate development of secondary sexual characteristics e.g. breast development/ hips broadening
what is an example of an oestrogen hormone
oestradiol
what are other examples of puberty blockers (4)
goserelin
histrelin
leuprolide
triptorelin
what are puberty blockers traditionally used in
treatment of breast or prostate cancers
how do gonadotropin-releasing hormone (GnRH) agonists work
diretly stimulating the gonadotropin-releasing hormone receptor (GnRHR) in the pituitary gland
do not quickly dissociate
what is the initial impact of the gonadotropin-releasing hormone (GnRH) agonist binding to the gonadotropin-releasing hormone receptor (GnRHR)
flare effect
up to 10 fold increase in luteinising hormone
up to 2 fold increase in follicle stimulating hormone
what is the impact of the gonadotropin-releasing hormone (GnRH) agonist binding to the gonadotropin-releasing hormone receptor (GnRHR) after continuous administration
decrease in luteinising hormone and follicle secreting hormone
via receptor downregulation by internalisation of receptors
gonadotropin-releasing hormone receptors (GnRHR) removed from cell surface in pituitary gland, cannot interact with agonist anymore
result of The Cass Review
NHS england - puberty blockers not routine treatment for children with gender dysphoria
BMA - disagreed, calling for ban to be lifted
other than as a puberty blocker, what other role does gonadotropin-releasing hormone (GnRH) have
supressing endogenous sex hormone production
switch off body’s sex hormone production, cross sex hormones can be administered
in MTF, which gonadotropin-releasing hormone (GnRH) are injected to reduce testosterone production 2
goserelin
leuprorelin
why does administration of oestrogen lower testosterone
negative feedback in hypothalamic pituitary gonadal axis
why do MTF require anti androgen medication after oestrogen admin
testosterone levels are decreased to be low for a male but above normal range for a female after oestrogen admin alone
further inhibits testosterone
examples of anti-androgen medication aka MTF (3)
spironolactone
finasteride
cyproterone
what is spironolactone
mild antiandrogen
androgen receptor (AR) competitive antagonist
competes with androgen
what is the androgen receptor a target for (2)
testosterone
more potent androgen dihydrotestosterone (DHT) - produced from testosterone
what other function does spironolactone have
reduce effects of androgens produced by adrenal glands as well as testes
what can a high dose of spironolactone induce
breast development, feminization, lack of spontaneous erections
what is cyproterone
anti androgen
acts as an androgen receptor antagonist
helps counteract flare effect of gonadotropin-releasing hormone (GnRH) agonists, reduces testosterone surge
what is finasteride
inhibitor of enzyme 5α-reductase
what is the enzyme 5α-reductase responsible for
converstion of testosterone into DHT (more potent androgen)
what gonadotropin-releasing hormone (GnRH) agonists are injected for FTM (2)
goserelin
leuprorelin
examples of oestrogen blockers for FTM (2)
tamoxifen (oestrogen receptor antagonists)
anastrozole (aromatase inhibitors)
what does endogenous oestrogen bind to
oestrogen receptor (ER)
what occurs once the ER-oestrogen receptor complex is formed
translocates to nucleus
activates gene transcription and translation of oestrogen-regulated genes
tamoxifen mechanism of action
selective oestrogen receptor modulator - certain tissues e.g. dec breast tissue
oestrogen receptor antagonist, prevents oestrogen binding/ activating
reduces oestrogen effects
what is anastrozole FTM mechanism of action
aromatase enzyme inhibitor
aromatase coverts androgens to oestrogens
inhibitor thus reduces oestradiol and inc testosterone levels
what GnRH agonists are used MTF
goserelin
leuprorelin
what GnRH agonists are used FTM
goserelin
leuprorelin
what cross sex hormones are used MTF
oestrogens
what cross sex hormones are used FTM
testosterone
what hormone receptor antagonists are used MTF
spironolactone
cyproterone
what hormone receptor antagonists are used FTM
tamoxifen
what hormone production inhibitors are used MTF
finasteride
what hormone production inhibitors are used FTM
anastrozole
risks/ side effects of testosterone therapy
polycythaemia - inc rbc in blood
risks/ side effects of oestrogen therapy
venous thromboembolisms (VTE)
risks/ side effects of both oestrogen and testosterone therapy
inc cvd risk
inc development of type 2 diabetes
impaired fertility
what is aromatase
enzyme
converting androgens (male sex hormones) into estrogens (female sex hormones)
MTF effects
redistrubution of body fat
dec muscle mass
softer less oily skin
testicular atrophy
breast development
FTM effects
vaginal atrophy
cessation of menses
clitoral enlargement
increased muscle mass
deepening of voice
world professional association for transgender health (WPATH)
advocates for informed consent prior to hormone therapy
encourages puberty blockers before surgical change in childhood as puberty blockers are reversible
how is goserelin administered
subcutaneous implant in abdominal wall
histrelin
gonadotropin-releasing hormone analog
suppresses sex steroid production
oestradiol administration vs oestrogen administration
serum estradiol is easier monitored
but, more expensive than oestrogen admin
oestradiol administration side effects
inc. insulin resistance
inc. weight gain
transdermal oestradiol
bypasses hepatic 1st pass metabolism, avoids liver reduces clotting, so reduces thromboembolic risk
ethinylestradiol
oral synthetic estrogen
inc first pass metabolism, inc thromboembolic risk
oral testosterone
inc liver toxicity risk due to inc liver enzyme levels
transdermal/ parenteral admin preferred
monitoring
continuous screening and monitoring of hormone levels
cervical cancer screening if cervical tissue present
summarise puberty blockers
GnRH agonists - safe, efficacious way to inhibit development of secondary sex characteristics
anti-androgens - facilitate development of feminising characteristics - less cost effective than GnRH and also is more commonly used comcomitantly with estrogen therapy
cross sex hormones - induce secondary sexual characteristics after piberty blockers used
ethical considerations - 4
informed consent, esp in minors as side effects may occur, esp long term ones
avoids gender affirming surgeries later in life e.g. chest reconstruction
Pediatric Health, Medicine, and Therapeutics journal - GRH agonist histrelin is effective, checking serum hormone level monitoring vital/access is limited - expensive, relevant as gender dysphoria inc risk of anxiety, depression
Journal of Health ethics article - treatment be initiated when the patient is in the stage where a child has had some
experience of his/her biological gender and can therefore make a logical decision
Leuprolide admin
intramuscular injection
Supprelin or Histrelin admin
implant under dkin, releases agent over period of one year
GnRH Agonists mechanism of action
gonadotropin-releasing hormone (GnRH) produced in hypothalamus, carried via blood vessel to GnRHR
GnRH agonist stimulating the gonadotropin-releasing hormone receptor (GnRHR) in the pituitary gland, same effect
downregulation
decrease in luteinising hormone and follicle secreting hormone
suppress release of gondotropins LH FSH from pituitary gland
dec in sex hormones (testosterone or estrogen)
(GnRHR) removed from cell surface in pituitary gland, cannot interact with agonist anymore
in MFT, usually used before estrogen therapy
anti androgen spironolactone mechanism of action
aldosterone antagonist, also blocks androgen receptors
dec testosterone
how are cross sex hormones admin
basically estrogen therapy is usually with anti androgens
testosterone therapy is usually after GnRH agonist to suppress endogenous oestrogen production
main types of med classes we gaf about - 4
cross sex hormones
puberty blockers - gonadotropin-releasing hormone (GnRH) agonists
anti androgen medication post oestrogen admin aka testosterone blockers and antag
oestrogen blockers and antag
meds for each class we gaf about - 11
cross sex hormones - oestradiol, oestrogen, testosterone
puberty blockers - goserelin, histrelin, leuprolide, triptorelin
anti androgen med - spironolactone, cyproterone ( aldosterone and androgen receptor antag)
oestogen blockers - tamoxifen (oes antag), anastrozole (aromatase inhibitors)
extra we gaf about
ethinylestradiol